Free Trial

ZIVO Bioscience Q1 2023 Earnings Report

ZIVO Bioscience logo
$19.25 +3.38 (+21.30%)
(As of 12/18/2024 03:58 PM ET)

ZIVO Bioscience EPS Results

Actual EPS
-$1.26
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ZIVO Bioscience Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ZIVO Bioscience Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

ZIVO Bioscience Earnings Headlines

Harmony Biosciences Holdings
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Regencell Bioscience Holdings Ltd RGC
ZIVO Bioscience Announces Uplisting to OTCQB Market
Ideaya Biosciences
See More ZIVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ZIVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZIVO Bioscience and other key companies, straight to your email.

About ZIVO Bioscience

ZIVO Bioscience (NASDAQ:ZIVO), a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

View ZIVO Bioscience Profile

More Earnings Resources from MarketBeat

Upcoming Earnings